Reviews
Summary
Positives
- Rosuvastatin is one of the statins listed by the Shoemaker protocol as effective at the 80 mg dose to lower elevated C3a in CIRS Surviving Mold.
- Many patients tolerate Crestor with only mild, self-limiting headache, nausea, or constipation early on Healthline.
Negatives
- A patient on Crestor reported feeling depressed, unmotivated, and weak with worsening fatigue and joint aches after about three months Drugs.com.
- Some reviewers described severe muscle and joint pain, foamy urine, and a rise in blood glucose at just 10 mg per day Drugs.com.
Hurdles & Side Effects
- Patients with overlapping ME/CFS-like fatigue often can't distinguish whether new fatigue and weakness is the statin or the underlying CIRS Drugs.com.
- Patients on rifampin earlier in the CIRS protocol may need extra time off rifampin before rosuvastatin levels stabilize because of CYP450 induction Mayo Clinic.
Was this summary accurate?
Tell us how this treatment affected you
Patient reviews are the engine that keeps this page helpful. Whether you improved tremendously, got worse, or landed somewhere in between, your story helps someone with similar conditions make a more intelligent decision.
Find care
Get Rosuvastatin
Providers
0 matches
No linked providers yet.
Pharmacies
0 matches
No linked pharmacies yet.